Geode Capital Management, LLC Rani Therapeutics Holdings, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$4.89 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.35 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$937,8091.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$852,1340.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$575,2110.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $46.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...